21 results
PRE 14A
RVNC
Revance Therapeutics Inc
12 Mar 21
Preliminary proxy
4:13pm
to healthcare and leading with business ethics, compliance and strong governance. We encourage you to read the report on our website. As part of our ESG … personal integrity and ethics, (B) relevant expertise upon which to be able to offer advice and guidance to management, (C) demonstrated excellence
8-K
EX-3.1
na4znven4fm10la2 13
15 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:04pm
10-K
oj6pftghk0eyb9nwg2
28 Mar 14
Annual report
12:00am
DRS
agsin
19 Apr 13
Draft registration statement
12:00am
S-1
j688z11qp6 uhpuk2cc
31 Dec 13
IPO registration
12:00am
424B4
1wuadnk 401g
6 Feb 14
Prospectus supplement with pricing info
12:00am